Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amisha S Raikar

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Materials (Basel, Switzerland)|November 14, 2023
Surface Engineering of Bioactive Coatings for Improved Stent Hemocompatibility: A Comprehensive ReviewAmisha S Raikar, Sushma Priya, Shilpa P Bhilegaonkar, et al.
EXCLI Journal|February 16, 2026
Development of nanoparticle-based Toll-like receptor agonists for respiratory immunotherapyAmisha S Raikar, Ananya Verma, Mayuri B Naik, et al.
Current Pharmaceutical Design|October 31, 2025
VLP-based Cancer Therapy: Past, Present, and Future ProspectsAmisha S Raikar, Swaroop Kumar Pandey, Ayush Kulshreshtha, et al.
Heliyon|January 16, 2024
Overview of processed excipients in ocular drug delivery: Opportunities so far and bottlenecksSumel Ashique, Neeraj Mishra, Sourav Mohanto, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Materials (Basel, Switzerland)|November 14, 2023
Surface Engineering of Bioactive Coatings for Improved Stent Hemocompatibility: A Comprehensive ReviewAmisha S Raikar, Sushma Priya, Shilpa P Bhilegaonkar, et al.
EXCLI Journal|February 16, 2026
Development of nanoparticle-based Toll-like receptor agonists for respiratory immunotherapyAmisha S Raikar, Ananya Verma, Mayuri B Naik, et al.
Current Pharmaceutical Design|October 31, 2025
VLP-based Cancer Therapy: Past, Present, and Future ProspectsAmisha S Raikar, Swaroop Kumar Pandey, Ayush Kulshreshtha, et al.
Heliyon|January 16, 2024
Overview of processed excipients in ocular drug delivery: Opportunities so far and bottlenecksSumel Ashique, Neeraj Mishra, Sourav Mohanto, et al.
Pageof 1